Dementia
Dementia
‘Dementia’ is an umbrella term for a number of progressive, organic brain diseases that affect approximately 850,000 people in the UK. Most neurodegenerative diseases leading to dementia are characterized by processes that result in the aberrant polymerization of proteins. A small proportion of individuals with these diseases develop dementia as a direct result of mutations or polymorphisms in genes influencing these processes. The most common cause of dementia is Alzheimer's disease. Other important causes include vascular dementia, dementia with Lewy bodies and fronto-temporal dementia. The management of dementia largely focuses on helping patients and families to cope with increasing care needs as the disease progresses, and with the emergence of troublesome neuropsychiatric symptoms. Current pharmacological treatments are based on the neurochemical changes that are found in these diseases. Cholinesterase inhibitors and N-methyl-d-aspartate receptor antagonists offer some help in ameliorating the inevitable cognitive decline found in Alzheimer's disease. However, the treatment of neuropsychiatric symptoms in dementia is still largely empirical and is hampered by either limited efficacy or troublesome adverse effects.
Alzheimer's disease, MRCP, cognitive deficits, dementia, dementia with Lewy bodies, fronto-temporal dementia, vascular dementia
742-745
Holmes, Clive
ada5abf3-8459-4cf7-be40-3f4e9391cc96
Amin, Jay
692a8880-70ff-4b64-a7e9-7d0d53449a30
November 2020
Holmes, Clive
ada5abf3-8459-4cf7-be40-3f4e9391cc96
Amin, Jay
692a8880-70ff-4b64-a7e9-7d0d53449a30
Abstract
‘Dementia’ is an umbrella term for a number of progressive, organic brain diseases that affect approximately 850,000 people in the UK. Most neurodegenerative diseases leading to dementia are characterized by processes that result in the aberrant polymerization of proteins. A small proportion of individuals with these diseases develop dementia as a direct result of mutations or polymorphisms in genes influencing these processes. The most common cause of dementia is Alzheimer's disease. Other important causes include vascular dementia, dementia with Lewy bodies and fronto-temporal dementia. The management of dementia largely focuses on helping patients and families to cope with increasing care needs as the disease progresses, and with the emergence of troublesome neuropsychiatric symptoms. Current pharmacological treatments are based on the neurochemical changes that are found in these diseases. Cholinesterase inhibitors and N-methyl-d-aspartate receptor antagonists offer some help in ameliorating the inevitable cognitive decline found in Alzheimer's disease. However, the treatment of neuropsychiatric symptoms in dementia is still largely empirical and is hampered by either limited efficacy or troublesome adverse effects.
Text
44-11 Amin Holmes new 2020 v2
- Accepted Manuscript
More information
Accepted/In Press date: 18 May 2020
e-pub ahead of print date: 6 October 2020
Published date: November 2020
Keywords:
Alzheimer's disease, MRCP, cognitive deficits, dementia, dementia with Lewy bodies, fronto-temporal dementia, vascular dementia
Identifiers
Local EPrints ID: 444368
URI: http://eprints.soton.ac.uk/id/eprint/444368
ISSN: 1357-3039
PURE UUID: 7fe2b527-9968-4a37-9bef-cf334bac825b
Catalogue record
Date deposited: 14 Oct 2020 16:31
Last modified: 30 Nov 2024 05:04
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
